Clinical Trial Update: Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating non-inferiority and safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate in patients with hematologic malignancies requirin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Hepatitis in Prophylaxis Context

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Yonsei University | Conditions: Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication | Phase 4 | Status: NOT_YET_RECRUITING